Corvus Pharmaceuticals Inc (CRVS) Analysis & Forecast for 2024
Corvus Pharmaceuticals Inc (NASDAQ: CRVS) is 30.11% higher on its value in year-to-date trading and has touched a low of $0.61 and a high of $4.19 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]